Article Information
History
- May 26, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Meera Varshneya1,
- Itziar Irurzun-Arana1,
- Chiara Campana1,
- Rafael Dariolli1,
- Amy Gutierrez1,
- Taylor K. Pullinger1 and
- Eric A. Sobie1,*
- 1Department of Pharmacological Sciences & Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*Editorial Correspondence: Eric A. Sobie, One Gustave Levy Place, Box 1677, New York, NY 10029, USA; eric.sobie{at}mssm.edu email: eric.sobie{at}mssm.edu
Posted May 26, 2020.
Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions
